Evidence map›Paper›PMID 30807653›Full record

ArticleInternational journal of cancer2020

Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

Aurora Perez-Cornago, Inge Huybrechts, Paul N Appleby, Julie A Schmidt, Francesca L Crowe, Kim Overvad, Anne Tjønneland, Tilman Kühn, Verena Katzke, Antonia Trichopoulou and 21 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in International journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 12 countries.

Aurora Perez-CornagoCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-5652-356X
Inge HuybrechtsDietary Exposure Assessment Group, International Agency for Research on Cancer, Lyon, France.
Paul N ApplebyCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Julie A SchmidtCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-7733-8750
Francesca L CroweInstitute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Kim OvervadDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus C, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Tilman KühnDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Anna KarakatsaniHellenic Health Foundation, Athens, Greece.
Eleni PeppaHellenic Health Foundation, Athens, Greece.
Sara GrioniEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Domenico PalliCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.ORCID 0000-0002-8008-5096
Rosario TuminoDepartment of Cancer Registry and Histopathology, "Civic - M.P. Arezzo" Hospital ASP, Ragusa, Italy.
H Bas Bueno-de-MesquitaDepartment for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Nerea LarrañagaDepartment of Basque Regional Health, Public Health Division of Gipuzkoa-BIODONOSTIA, Guipúzcoa, Spain.
Maria-Jose SánchezCIBER of Epidemiology and Public Health, Madrid, Spain.
J Ramón QuirósPublic Health Directorate, Asturias, Spain.
Eva ArdanazCIBER of Epidemiology and Public Health, Madrid, Spain.
María-Dolores ChirlaqueCIBER of Epidemiology and Public Health, Madrid, Spain.
Antonio AgudoUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.
Anders BjartellDepartment of Translational Medicine, Medical Faculty, Lund University, Malmö, Sweden.
Peter WallströmNutrition Epidemiology Research Group, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Veronique ChajesDepartment of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-1297-3064
Konstantinos K TsilidisDepartment of Hygiene and Epidemiology, University of Ioannina, School of Medicine, Ioannina, Greece.ORCID 0000-0002-8452-8472
Dagfinn AuneDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Timothy J KeyCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
University of Oxford · GBCentre international de recherche sur le cancer · FRGerman Cancer Research Center · DEHellenic Health Foundation · GRPiedmont Reference Center for Epidemiology and Cancer Prevention · ITAarhus University · DKAzienda Usl 8 Arezzo · ITBasque Government · ESDanish Cancer Society · DKFondazione IRCCS Istituto Nazionale dei Tumori · ITGobierno del Principado de Asturias · ESImperial College London · GBInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Salud Pública de Navarra · ESLund University · SEMalmö University · SENational and Kapodistrian University of Athens · GROslo University Hospital · NORegional Health · USUniversidad de Granada · ES

Funding

Cancer Research UK 19170Cancer Research UK 29017Cancer Research UK C8221/A19170Medical Research Council 1000143Medical Research Council 14136Medical Research Council C570/A16491Medical Research Council MR/M012190/1World Health Organization 001
6 · The paper itself

Abstract

The associations of individual dietary fatty acids with prostate cancer risk have not been examined comprehensively. We examined the prospective association of individual dietary fatty acids with prostate cancer risk overall, by tumor subtypes, and prostate cancer death. 142,239 men from the European Prospective Investigation into Cancer and Nutrition who were free from cancer at recruitment were included. Dietary intakes of individual fatty acids were estimated using center-specific validated dietary questionnaires at baseline and calibrated with 24-h recalls. Multivariable Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). After an average follow-up of 13.9 years, 7,036 prostate cancer cases and 936 prostate cancer deaths were ascertained. Intakes of individual fatty acids were not related to overall prostate cancer risk. There was evidence of heterogeneity in the association of some short chain saturated fatty acids with prostate cancer risk by tumor stage (p

Indexed as

AdultAgedDietary FatsFatty AcidsHumansMaleMiddle AgedProspective StudiesProstatic NeoplasmsRisk FactorsDietary FatsFatty Acidsindividual fatty acidsprospectiveprostate cancertumor subtypes

Identifiers

PMID30807653
PMCPMC6899744
OpenAlexW2917752030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.